BlackRock Inc. - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$63,119,929
-3.1%
6,921,045
+12.4%
0.00%0.0%
Q2 2023$65,145,312
-0.8%
6,157,402
+14.7%
0.00%0.0%
Q1 2023$65,666,626
+2.5%
5,369,307
+4.0%
0.00%0.0%
Q4 2022$64,070,795
-3.9%
5,162,836
+5.8%
0.00%0.0%
Q3 2022$66,650,000
-26.7%
4,879,308
-1.7%
0.00%
-33.3%
Q2 2022$90,957,000
+14.3%
4,962,089
+0.3%
0.00%
+50.0%
Q1 2022$79,554,000
+11.5%
4,947,345
-2.9%
0.00%0.0%
Q4 2021$71,330,000
-23.9%
5,095,026
+1.9%
0.00%
-33.3%
Q3 2021$93,678,000
-9.5%
5,001,416
+0.8%
0.00%0.0%
Q2 2021$103,466,000
-29.9%
4,962,381
-5.0%
0.00%
-25.0%
Q1 2021$147,669,000
-8.3%
5,223,546
+5.9%
0.00%
-20.0%
Q4 2020$161,079,000
+19.9%
4,931,956
+12.5%
0.01%0.0%
Q3 2020$134,329,000
+90.0%
4,384,104
+1.1%
0.01%
+66.7%
Q2 2020$70,701,000
+141.1%
4,337,512
+47.1%
0.00%
+200.0%
Q1 2020$29,329,000
-28.8%
2,947,766
-1.5%
0.00%
-50.0%
Q4 2019$41,164,000
-8.7%
2,993,752
+0.7%
0.00%0.0%
Q3 2019$45,088,000
-4.9%
2,972,189
+23.5%
0.00%0.0%
Q2 2019$47,396,000
+21.8%
2,407,038
+2.6%
0.00%0.0%
Q1 2019$38,918,000
+15.0%
2,345,783
-2.7%
0.00%0.0%
Q4 2018$33,836,000
-19.3%
2,409,979
+0.6%
0.00%0.0%
Q3 2018$41,932,000
+15.1%
2,396,137
+19.7%
0.00%0.0%
Q2 2018$36,440,000
+21.8%
2,002,265
+25.5%
0.00%
+100.0%
Q1 2018$29,910,000
+28.2%
1,595,302
+4.6%
0.00%0.0%
Q4 2017$23,331,000
+52.6%
1,524,817
+49.1%
0.00%0.0%
Q3 2017$15,287,000
+176.3%
1,022,521
+71.9%
0.00%
Q2 2017$5,532,000
+1512.8%
594,895
+1427.1%
0.00%
Q1 2017$343,00038,9570.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders